Amgen Inc (AMGN)

Patent lawyers are intrigued and competitors will likely challenge, but the move to transfer ownership of the patent to the Saint Regis Mohawk tribe could cause other companies to try a similar tack.

Amgen sets to offer a competitor to Roche's Avastin.

Data Supports Safety and Efficacy of Repatha in Patients With Diabetes

Approval Based on Totality of Evidence From Global Development Program Showing MVASI™ is Highly Similar to Avastin® (bevacizumab)

We would suggest doing some buying here.

EVENITY Followed by Alendronate Reduced the Incidence of New Vertebral, Clinical, Non-Vertebral and Hip Fractures Compared to Alendronate Alone

Study Between ABP 980 and Trastuzumab in Patients With HER2-Positive Early Breast Cancer Adds to the Totality of Evidence of Biosimilarity

First Presentation of Detailed EVENITY ARCH Study Results and FRAME Extension Final Analysis

Aimovig Reduced Monthly Migraine Days for Patients With Chronic Migraine and Prior Treatment Failure, a Population With Significant Unmet Need

As a Miami resident, I've learned the value of hurricane preparation and the 'Jensen Rules'.

As a Florida resident, I've learned the value of preparation and the 'Jensen Rules'.

Novel Investigational Drug is Designed to Block Thymic Stromal Lymphopoietin (TSLP) - An Upstream Driver of Inflammation in Asthma

Today's breakout move in the stock is a highlight of the surging sector.

Today's breakout move in the stock is a highlight of the surging sector.

FDA Sets PDUFA Target Action Date of April 30, 2018

Late-Breaking Clinical Trial Presented at ESC 2017

Data Supports Lower LDL-C Levels for High-Risk Cardiovascular Patients

The most recent short interest data has been released for the 08/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Program to Expand to Australia, Canada, China, France, Germany, Hong Kong SAR, Italy, Netherlands, and Singapore

KYPROLIS and Dexamethasone Reduced the Risk of Death by 21 Percent Compared to Velcade® (bortezomib) and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients

Repatha Used in Patients at High-Risk For Cardiovascular Events is Cost-Effective at Net Prices at or Below $9,669

Analysis Evaluates the Effect of Repatha in More Than 5,000 Patients With a History of Stroke

Partnership to Target Multiple Serious Diseases Using Real World Data Studies

Study Showed Lowering LDL-C With Repatha Did Not Impair Cognition